Form 4 for IGC IGC Pharma, Inc.
Accepted 2025-10-20 00:00:00 ET · period of report 2025-10-17 · accession 0001185185-25-001500 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-20 | 2025-10-17 | IGC | Mukunda Ram | CEO, Dir | G - Gift | $0.00 | -100.0K | 3.99M | -2% | $0 |
| DM | 2025-10-20 | 2025-10-17 | IGC | Mukunda Ram | CEO, Dir | A - Grant | $0.00 | +4.50M | 1.50M | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-17 | G | D | 100,000 | $0.00 | 3,992,678 | D | — | — | (F3) Gift of shares of the Company's common stock to the reporting person's children who do not share the reporting person's household. |
| 2 | Derivative | Options | 2025-10-17 | A | A | 3,000,000 | $0.00 | 3,000,000 | D | — · — to 2038-03-31 | 3,000,000 Common Stock | (F1) The Reporting Person was granted options exercisable at $0.35, vesting equally over the next three years starting on March 31, 2026. |
| 3 | Derivative | Options | 2025-10-17 | A | A | 1,500,000 | $0.00 | 1,500,000 | D | — · — to 2036-03-31 | 1,500,000 Common Stock | (F2) The Reporting Person was granted Options subject to vesting according to specific milestones set by the Company's Board of Directors. The Options vest when milestones are achieved. The exercise price is $0.35. |